Portal-systemic shunts reduce asialoglycoprotein receptor density in rats

Journal of Nuclear Medicine

Volumn 42, Issue 1, 2001, Pages 110-116

  Colquhoun, S D ^a   Connelly, C A ^a   Vera, D R ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

99mTc diethylenetriaminepentaacetic acid galactosyl neoglycoalbumin; Hepatic blood flow; Liver; Quantitative functional imaging

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMMONIA; ASIALOGLYCOPROTEIN RECEPTOR; GALACTOSYLNEOGLYCOALBUMIN TC 99M; PENTETATE TECHNETIUM TC 99M; RADIOLIGAND;

AMMONIA BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMAGING SYSTEM; LIVER CIRRHOSIS; LIVER FUNCTION; NONHUMAN; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY;

ANIMALS; ASIALOGLYCOPROTEIN RECEPTOR; ASIALOGLYCOPROTEINS; LIVER; LIVER CIRCULATION; PORTAL SYSTEM; PORTASYSTEMIC SHUNT, SURGICAL; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TECHNETIUM TC 99M PENTETATE;

EID: 0035133772     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Hepatic recognition and catabolism of serum glycoproteins
2. Decreased hepatic function in patients with hepatoma or liver metastasis monitored by a hepatocyte-specific galactosylated radioligand
3. 99mTc-galactosyl-neoglycoalbumin
4. Quantitative assessment of hepatocellular function via in vivo radioreceptor imaging: Technetium-99m-galactosyl human serum albumin (Tc-GSA)
5. Scintigraphic evaluation of functional hepatic mass in patients with advanced breast cancer
6. Evaluation of hepatocellular function via receptor-mediated uptake of a technetium-99m-labeled asialoglycoprotein analogue
7. In vivo functional imaging using receptor-binding radiopharmaceuficals: Technetium-99m-galactosyl-neoglycoalbumin as a model
8. Hepatic binding protein: The galactose-specific receptor of mammalian hepatocytes
9. Technetium-99m NGA functional hepatic imaging: Preliminary clinical experience
10. Tc-99m galactosyl-neoglycoalbumin: In vivo characterization of receptor-mediated binding
11. Idenfifiability analysis of an in vivo receptor-binding radiopharmacokinefic system
12. Validation of in vivo receptor measurements via in vitro radioassay: Technetium-99m-galactosyl-neoglycoalbumin as a prototype model
13. 99mTc]galactosyl-neoglycoalbumin is sensitive to receptor quantity
14. 99mTc]galactosyl-neoglycoalbumin
15. Diagnostic performance of a receptor-binding radiopharmacokinefic model
16. Local identifiability of a receptor-binding radiopharmacokinetic system having measured parameters of known uncertainty
17. Synthesis and radiolabeling of galactosyl human serum albumin
18. [Tc-99m]galactosyl-neoglycoalbumin: Preparation and preclinical studies
19. [Tc-99m]galactosyl-neoglycoalbumin: In vivo characterization of receptor-mediated binding to hepatocytes
20. Arterial ketone body ratio in liver surgery
21. Hyperasialoglycoproteinemia in patients with chronic liver diseases and/or liver cell carcinoma: Asialoglycoprotein receptor in cirrhosis and liver cell carcinoma
22. Receptor index via hepatic asialoglycoprotein receptor imaging: Correlation with chronic hepatocellular damage
23. Estimation of remnant liver function before hepatectomy by means of technetium-99m-diethylene riamine-pentaacetic acid galactosyl human albumin
24. 99mTc-GSA) liver scintigraphy
25. Regulation of the human asialoglycoprotein receptor by cAMP
26. Different zonal distribution of the asialoglycoprotein receptor, the a2-macroglobulin receptor/low-density-lipoprotein receptor-related protein and the lipoprotein-remnant receptor of rat liver parenchymal cells
27. Impairment of the asialoglycoprotein receptor by ethanol oxidation
28. Decreased binding of asialoglycoproteins to hepatocytes from ethanol-fed rats
29. Ethanol inhibits asialoglycoprotein receptor synthesis but augments its mRNA expression in human hepatoma cell line
30. Abnormal surface distribution of the human asialogiycoprotein receptor in cirrhosis
31. Protein-restricted diet alters concentration of plasma membrane glycoproteins in rat liver
32. Chloroquine reduces the number of asialo-glycoprutein receptors in the hepatocyte plasma membrane
33. Effects of vasopressin on receptor-mediated endocytosis of asialogiycoprotein by hepatocytes from normal and diabetic rats
34. Posttranscriptional regulation of mRNA levels in rat liver associated with deoxycholic acid feeding
35. The Eck fistula rat: Definition of an experimental model
36. Experimental evaluation of liver atrophy and portacaval shunt
37. Haemostatic and immunologic sequelae of portacaval shunt in rats
38. Treatment of bleeding esophagogastric varices due to extrahepatic portal hypertension: Results of portal-systemic shunts during 35 years
39. Effect of a transjugular intrahepatic portosystemic shunt on liver biochemical profiles
40. The clearance rate of chylomicron retinyl ester from plasma can be used to distinguish rats with cirrhosis from those with portacaval shunt